
Corporate Action5 Sept 2026, 01:30 pm
Asston Pharma Allots 24.1 Lakh Shares via Preferential Issue
AI Summary
Asston Pharmaceuticals Ltd announced the allotment of 24,10,431 equity shares through a preferential issue. The shares were issued at a price of ₹115 each, including a premium of ₹105 per share. This allotment increases the company's paid-up equity share capital to ₹10,92,27,910, comprising 1,09,22,791 equity shares of face value ₹10 each. The board meeting where this was approved commenced at 10:30 AM and concluded at 10:45 AM on September 05, 2026. The newly allotted shares will rank pari passu with existing equity shares.
Key Highlights
- 24,10,431 equity shares allotted via preferential issue.
- Issue price fixed at ₹115 per share, including ₹105 premium.
- Paid-up equity share capital increased to ₹10,92,27,910.
- Allotted shares rank pari passu with existing shares.
- Board approved allotment in a meeting on September 05, 2026.
Price Impact
More from APL